T. Burkard

Discipline

Education (1) Anthropologie biologique (1)

Type de document

Articles (9)

Co-auteur

Date

Source

Mot-clé

Patients (9) Patients (9) Treatment (7) Swiss (7) cohorte (7) gestion (6) Rheumatoid arthritis (6) Management (6) Human beings (6) Management (6) Use (6) thérapie (5) maladie (5) Women (5) Ci (Chinese poetry) (5) Therapeutics (5) Rheumatism (5) Arthritis (5) Women (5) Quality (5) maladie (5) Drugs (4) temps (durée) (3) risque (3) danger (3) âge (3) Time (3) Risk (3) Older people (3) Age (3)

Documents écrit par T. Burkard (9) | parle de T. Burkard (0)

Management of patients with hypertension and chronic kidney disease referred to Hypertension Excellence Centres among 27 countries. On behalf of the European Society of Hypertension Working Group on Hypertension and the Kidney.
J.M. Halimi et al.
Longitudinal associations between body mass index and changes in disease activity and radiographic progression in rheumatoid arthritis patients treated with infliximab.
T. Burkard et al.
Patient groups in Rheumatoid arthritis identified by deep learning respond differently to biologic or targeted synthetic DMARDs.
M. Kalweit et al.
May Measurement Month 2017-2019: results from Switzerland.
A. Damianaki et al.
The associations between bariatric surgery and hip or knee arthroplasty, and hip or knee osteoarthritis: Propensity score-matched cohort studies.
T. Burkard et al.
Interruptions of biological and targeted synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis: a descriptive cohort study assessing trends in patient characteristics in Switzerland.
T. Burkard et al. (15 mars 2022)
Lower odds of remission among women with rheumatoid arthritis: A cohort study in the Swiss Clinical Quality Management cohort.
J.N. Pfund et al. (2022)
Increased radiographic progression of distal hand osteoarthritis occurring during biologic DMARD monotherapy for concomitant rheumatoid arthritis.
C.A. Lechtenboehmer et al. (26 oct. 2021)
Prediction of sustained biologic and targeted synthetic DMARD-free remission in rheumatoid arthritis patients.
T. Burkard et al. (2021)